Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Am J Cardiol. 2017 Jun 15;120(5):782–785. doi: 10.1016/j.amjcard.2017.06.007

Table 2.

Risk for Atrial Fibrillation (N=13,840)

Events/No. At Risk Model 1*
OR (95%CI)
P-value Model 2
OR (95%CI)
P-value P-interaction
APC
 No 876/12,890 Ref - Ref - -
 Yes 139/950 1.94 (1.58, 2.36) <0.001 1.92 (1.57, 2.35) <0.001
Race
 Black 221/5,123 1.84 (1.23, 2.74) 0.0027 1.78 (1.19, 2.67) 0.0051 0.56
 White 794/8,717 1.98 (1.57, 2.50) <0.001 1.98 (1.57, 2.50) <0.001
Sex
 Female 436/7,776 1.91 (1.39, 2.61) <0.001 1.95 (1.42, 2.68) <0.001 0.66
 Male 579/6,064 1.99 (1.54, 2.58) <0.001 1.93 (1.49, 2.51) <0.001
*

Adjusted for age, sex, race, education, income, and geographic region.

Adjusted for Model 1 covariates plus systolic blood pressure, high-density lipoprotein cholesterol, total cholesterol, body mass index, smoking, diabetes, antihypertensive medications, left ventricular hypertrophy, and prior cardiovascular disease.

Interactions tested using Model 2.

APC=atrial premature complex; CI=confidence interval; OR=odds ratio.